FDA recalls 2.2 million at-home coronavirus tests due to false positives

Posted on AllSides November 12th, 2021
From The Right

The FDA announced this week that the recall of more than 2.2 million at-home COVID-19 tests by digital diagnostics firm Ellume is being classified as a class 1 recall, which is the most serious type due to the potential for "serious adverse health consequences or death."

Ellume's at-home test detects proteins from the SARS-CoV-2 virus through a less invasive nasal swab than the one that health providers normally use. 

The recall is due to a "manufacturing issue" that was first identified by the company last month and could lead to a false-positive result. 

The FDA...

Read full story

Fox Business

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
See full bias rating for Fox Business
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right